From PCOS to PMOS
What it means and why…
If you've recently seen references to PMOS and wondered whether it's something new, the answer is both yes and no…
In May 2026, an international group of experts officially announced that Polycystic Ovary Syndrome (PCOS) will be renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). While the condition itself hasn't changed, the new name reflects a much better understanding of what it actually is.
Why change the name?
For years, many doctors and patients have felt that the term Polycystic Ovarian Syndrome was misleading.
Firstly, many women with PCOS don't actually have polycystic ovaries on ultrasound. Equally, some women have polycystic-looking ovaries but don't have the condition. The "cysts" seen on scans are not true cysts at all, but rather immature follicles that have not developed normally.
Secondly, the name focuses attention on the ovaries, when we now know that the condition affects much more than reproductive health.
PCOS is a complex hormonal and metabolic condition that can affect weight regulation, insulin sensitivity, cardiovascular health, skin, fertility, mental wellbeing, and long-term health risks. The new name aims to better reflect this broader picture.
What does PMOS stand for?
Polyendocrine Metabolic Ovarian Syndrome
While it may sound more complicated, each word has been chosen carefully:
Polyendocrine recognises that multiple hormone systems are involved.
Metabolic highlights the important role of insulin resistance and metabolic health.
Ovarian acknowledges the reproductive aspects of the condition.
Syndrome reflects that it presents differently from woman to woman.
Does this change anything for patients?
In practical terms, very little changes.
If you have previously been diagnosed with PCOS, your diagnosis remains valid. You do not need new tests or reassessment simply because of the name change. Treatment approaches remain largely the same, and there will be a gradual transition period before PMOS becomes fully established in clinical guidelines and everyday practice.
However, the name change does have some important implications.
By recognising PMOS as a whole-body condition rather than simply a gynaecological disorder, healthcare professionals may be more likely to consider the wider health impacts, including:
Insulin resistance
Type 2 diabetes risk
Cardiovascular health
Weight management
Mental health and wellbeing
Long-term prevention strategies
For many women, this broader understanding feels validating. Symptoms such as fatigue, weight struggles, anxiety, or metabolic issues have often been dismissed or treated separately, when they may all be connected to the same underlying condition.
The bottom line
The move from PCOS to PMOS is not about changing the condition—it is about changing the way we think about it.
The hope is that a more accurate name will lead to earlier diagnosis, better understanding, more targeted research, and a more holistic approach to treatment.
At Clinic51, we welcome this shift. Women with PMOS deserve care that looks beyond fertility alone and considers their long-term metabolic, cardiovascular and overall health.
After all, the name may be changing, but the goal remains the same: helping women understand their bodies and access the support they need to thrive.
If you are experiencing symptoms related to PMOS, or any menstrual health issues – we offer Menstrual Health Consultations at Clinic51 with Consultant Obstetrician & Gynaecologist Dr Leah Deutsch. In our appointments we are able to take the time to listen, fully explore your symptoms, and work with you to find a plan of action.
To find out more visit the Menstrual Health page of our website, or email or call our friendly reception team who can answer any questions you may have: 01798 667 151 / info@clinic51.co.uk
